- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04152239
Utility of Motorized Spiral Enteroscopy for Suspected Small Bowel Pathology (MSESB)
Prospective Evaluation of the Utility of Motorized Spiral Enteroscopy in Patients With Suspected Small Bowel Pathology
Diagnosis and treatment of small bowel pathologies remain challenging due to the long length of the small bowel. Obscure gastrointestinal (GI) bleeding with negative upper and lower GI workup, suspected inflammatory bowel disease, and suspected tumors of the small bowel often require small bowel investigation.
While video capsule endoscopy (VCE) and computed tomography (CT) enteroclysis (CTE) are often the initial diagnostic modalities for suspected small bowel pathologies and can provide structural information of the small bowel mucosa, biopsy or therapy for the detected pathology could not be performed with VCE or CTE. In patients who require biopsy or therapy of the detected small bowel pathology, deep enteroscopy would be the procedure of choice in modern clinical practice before subjecting patient to surgery.
Diagnostic and therapeutic deep enteroscopy can be performed by balloon overtube assisted enteroscopy (eg, double balloon enteroscopy (DBE), single balloon enteroscopy (SBE) or spiral overtube assisted enteroscopy (SE). Despite the difference in equipment design of DBE, SBE, and SE, the concepts for small bowel intubation by pleating the intestine over the endoscope are the same behind these techniques. Depending on the location of the small bowel pathology reported by VCE or CTE, antegrade (oral route), retrograde (anal route), or combined antegrade and retrograde deep enteroscopy for total enteroscopy can be performed.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Diagnosis and treatment of small bowel pathologies remain challenging due to the long length of the small bowel. Obscure gastrointestinal (GI) bleeding with negative upper and lower GI workup, suspected inflammatory bowel disease, and suspected tumors of the small bowel often require investigations of the small bowel.
While video capsule endoscopy (VCE) and computed tomography (CT) enteroclysis (CTE) are often the initial diagnostic modalities for suspected small bowel pathologies and can provide structural information of the small bowel mucosa, biopsy or therapy for the detected pathology could not be performed with VCE or CTE. In patients who require biopsy or therapy of the detected small bowel pathology between the ligament of Treitz and ileocecal valve, deep enteroscopy would be the procedure of choice in modern clinical practice before subjecting patient to surgery.
Diagnostic and therapeutic deep enteroscopy can be performed by balloon overtube assisted enteroscopy (eg, double balloon enteroscopy (DBE), single balloon enteroscopy (SBE) or spiral overtube assisted enteroscopy (SE)). Despite the difference in equipment design of DBE, SBE, and SE, the concept for small bowel intubation by pleating the intestine over the endoscope is the same behind these techniques. Depending on the location of the small bowel pathology reported by VCE or CTE, antegrade (oral route), retrograde (anal route), or combined antegrade and retrograde deep enteroscopy for total enteroscopy can be performed. In patients with suitable anatomy, total enteroscopy by antegrade approach alone may be achieved.
DBE was introduced in 2001 and has been the most studied form of modern deep enteroscopy. In a recent systematic review of 12823 procedures, the overall diagnostic yield was found to be 68.1%. The pooled total enteroscopy rate was 44% by the combined anterograde and retrograde approach or antegrade-only approach. The pooled minor and major adverse event (eg, perforation, bleeding, pancreatitis, aspiration pneumonia) rates were 9.1% and 0.72%, respectively. Despite its clinical utility, long procedure time (usually more than 1 to 1.5 hour) and the need for 2-operators are often regarded as drawbacks of DBE. SE was subsequently designed to address this issue with the use of a spiral overtube by manual rotation for efficient small bowel intubation. When compared to balloon overtube assisted enteroscopy, the main advantage of SE is the relative reduction in procedure time. However, the total enteroscopy rate of SE is lower, mainly due to difficult overtube and endoscope passage in retrograde procedures. Adverse events with SE (eg, minor mucosal tears, perforation, etc) have been reported to be 0.3%. Because both DBE and SE have its own shortcomings, the need to further improve the current technology of deep enteroscopy has always been present.
Recently, a motorized spiral enteroscope (MSE) (Olympus Medical, Tokyo, Japan) has become available and has the potential to address the shortcomings of the DBE and SE. MSE is an enteroscope equipped with a short spiral overtube propelled by a endoscopist-controlled motor contained in the handle of the endoscope. The endoscopist controls the left-right and up-down movements by the usual manuvers while the forward or backward advancement of the enteroscope would be contolled by a foot pedal that activates the spiral overtube rotation. The basic principle of small bowel pleating over the endoscope by the use of an overtube to achieve deep small bowel intubation is similar to that of DBE and SE. During the procedure, a visual force gauge allows the operator to monitor the direction of overtube rotation and the resistance applied to the spiral overtube in the small bowel. If excessive rotational resistance is detected, the motor would be stopped automatically to avoid mucosal trauma in the intestine. The initial experience of MSE in patients with small bowel pathology and colonic pathology appears promising with a diagnostic yield of 76 - 88%, therapeutic yield of 76%, a total enteroscopy rate of 70% (combined antegrade and retrograde approaches or antegrade alone approach) and shorter procedure time (< 40 minutes). Based on data from three studies including a total of 110 MSE procedures, no serious adverse event such as perforation has been reported. The overall adverse event rate including erosion, mucosal tear, hematoma, transient swallowing discomfort, etc, was reported to be 20% in a study with 30 patients. Despite its potential to improve the clinical management of patients with small bowel disorders, current data on the diagnostic and therapeutic utility of MSE is from expert European centers and remains limited. Investigators therefore propose this study to evaluate the utility of the MSE in patients with suspected small bowel pathology.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Locations
-
-
New Territories
-
Sha Tin, New Territories, Hong Kong
- Recruiting
- Prince of Wales Hospital, The Chinese University of Hong Kong
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Age ≥ 18 years
- Patients with suspected small bowel pathology based on clinical presentation, small bowel imaging or capsule endoscopy indicated for diagnostic and/or therapeutic enteroscopy
- Written informed consent available
Exclusion Criteria:
- Contraindications for endoscopy due to comorbidities
- Unable to provide written informed consent
- Patients with known severe GI tract inflammation, intestinal obstruction, gastroesophageal varices that preclude a safe enteroscopy procedure
- Coagulopathy or thrombocytopenia that cannot be corrected by blood product transfusion
- Pregnant patients
- Moribund patients from terminal illnesses
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Study group
Study group includes consecutive patients with suspected small bowel pathology based on clinical presentation, small bowel imaging or capsule endoscopy indicated for diagnostic and/or therapeutic enteroscopy.
Patients fulfilling the inclusion criteria and without exclusion criteria would undergo MSE per study protocol.
|
Endoscopic Procedures MSE is a 1.6m enteroscope equipped with a single-use short spiral overtube propelled by a user-controlled motor contained in the handle of the endoscope.
The endoscopist controls the left-right and up-down movements by the usual manuvers while the forward or backward advancement of the enteroscope would be contolled by a foot pedal that activates the spiral overtube rotation.
Antegrade MSE, retrograde MSE, or combined antegrade and retrograde MSE would be performed as clinically indicated for diagnostic +/- therapeutic procedures.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Diagnostic yield
Time Frame: peri-procedure
|
Diagnostic yield: defined as successful identification of the suspected pathology based on clinical presentation, pre-MSE small bowel imaging or capsule endoscopy
|
peri-procedure
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Technical success
Time Frame: peri-procedure
|
- defined as successful advancement of enteroscope beyond the ligament of Treitz for antegrade procedures, or successful advancement of enteroscope proximal to the ileocecal valve for retrograde procedures
|
peri-procedure
|
Therapeutic yield
Time Frame: peri-procedure
|
Therapeutic yield: defined as successful endoscopic interventions such as treatment for GI bleeding, polypectomy, etc
|
peri-procedure
|
Insertion time
Time Frame: peri-procedure
|
Insertion time: defined as time to the maximal depth of insertion in small bowel
|
peri-procedure
|
Maximal depth of insertion in small bowel
Time Frame: peri-procedure
|
Maximal depth of insertion in small bowel
|
peri-procedure
|
Rate of total enteroscopy
Time Frame: peri-procedure
|
Rate of total enteroscopy achieved by antegrade approach alone or combined antegrade and retrograde approaches if total enteroscopy is indicated by findings on pre-MSE small bowel imaging or capsule endoscopy
|
peri-procedure
|
Adverse events related to procedure
Time Frame: peri-procedure
|
Adverse events related to procedure
|
peri-procedure
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- MSE SB study
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Small Bowel Disease
-
Odense University HospitalCompletedSimulation | Endoscopy | Education | Small Bowel Disease | Small Bowel Capsule EndoscopyDenmark
-
Asian Institute of Gastroenterology, IndiaCompletedSmall Bowel Disease | Small Bowel Ulcers | Capsule Endoscopy | Small Bowel Tumor
-
Medtronic - MITGCompletedInflammatory Bowel Disease | Small Bowel DiseaseUnited States
-
Aspero Medical, Inc.National Institutes of Health (NIH)RecruitingSmall Bowel DiseaseUnited States
-
Changhai HospitalShanghai Children's Hospital; Xian Children's HospitalNot yet recruitingSmall Bowel DiseaseChina
-
St. Antonius HospitalCompleted
-
Olympus Corporation of the AmericasUniversity of Florida; Rhode Island Hospital; University of Massachusetts, Worcester and other collaboratorsSuspendedSmall Bowel DiseaseUnited States
-
Asian Institute of Gastroenterology, IndiaRecruiting
-
Olympus Europe SE & Co. KGCompletedSmall Bowel DiseaseFinland, Germany, Belgium, Denmark, France, Norway
-
Wuhan Union Hospital, ChinaChanghai Hospital; Qilu Hospital of Shandong UniversityCompleted
Clinical Trials on Motorized spiral enteroscopy (MSE)
-
Evangelisches Krankenhaus DüsseldorfUniversité Libre de BruxellesUnknownSmall Bowel Disease
-
St. Antonius HospitalCompleted
-
Asian Institute of Gastroenterology, IndiaRecruiting
-
Evangelisches Krankenhaus DüsseldorfOlympusCompletedCrohn's Disease | Gastrointestinal Hemorrhage | Disorder of Small Intestine | Iron Deficiency Anaemia | Small Bowel Tumors | Intestinal Polyposis Syndrome | Coeliac DiseaseBelgium, Germany
-
Asian Institute of Gastroenterology, IndiaCompleted
-
Evangelisches Krankenhaus DüsseldorfOlympusCompletedAdenoma | Colonoscopy | Safety IssuesGermany